
Nano-X Imaging (NNOX) Stock Forecast & Price Target
Nano-X Imaging (NNOX) Analyst Ratings
Bulls say
Nano X Imaging is well-positioned to drive the world's transition to preventive health care with its integrated, cost-effective, and AI-based medical imaging platform. With a growing national footprint and partnerships with established regional players, the company has a strong potential for revenue growth, especially in the lucrative orthopedic market. Its DTS imaging is also reimbursable under an existing CPT code, making it easier for practices to adopt the technology.
Bears say
Nano X Imaging is facing significant challenges as they struggle to convert their U.S. distribution agreements into revenue, while also acknowledging the need for additional financing. It will be crucial for the company to demonstrate successful execution of their partnership-driven approach through new distribution agreements, initial system deployments, and increasing utilization at installed sites in order to drive meaningful revenue growth and validate their commercial model. Additionally, the company's shift towards a more outsourced manufacturing model may help to reduce capital intensity but comes with its own risks and costs.
This aggregate rating is based on analysts' research of Nano-X Imaging and is not a guaranteed prediction by Public.com or investment advice.
Nano-X Imaging (NNOX) Analyst Forecast & Price Prediction
Start investing in Nano-X Imaging (NNOX)
Order type
Buy in
Order amount
Est. shares
0 shares